The EXCEL Authors’ Answer to the BBC Investigation

Do to an investigation carried out by the BBC that led to the withdrawal of EACTS support from the latest coronary revascularization guidelines, the authors of the EXCEL study (indicated by this research) provided the following answers.

Escándalo con los resultados del EXCEL que hicieron “caer” las últimas guías

-Defining Peri-Procedural Infarction:

All researchers involved (including surgeons) agreed that the universal definition of infarction was not right for this study. This was because the universal definition criteria are different for PCI and surgery. Furthermore, their association to prognosis has not been shown. The EXCEL protocol criteria are uniform, and they have certainly been linked to prognosis.

The BBC investigation claims the research criteria were modified, which is absolutely incorrect. 

-Peri-procedural infarction rates were deliberately omitted:

Using the universal definition of infarction was one of the 35 exploratory secondary end points. The universal definition is based on troponins and, unfortunately, this data was missing in most patients. Therefore, there were no infarction reports using the universal definition criteria. Nevertheless, researchers were planning to report infarction rate according to multiple definitions, including of course the universal definition. 


Read also: Latest Guidelines “Dropped” After Scandal Over EXCEL Results.


-All cause mortality rate was not emphasized enough: 

All-cause mortality was a secondary end point and the sample had no statistical power to show anything. The modest difference in mortality between the groups was not adjusted, which made it impossible to draw any conclusions. Besides, mortality was caused mainly by sepsis and cancer several years after randomization, according to an events committee. A meta analyzis with 4394 patients from 4 randomized studies on PCI with DES vs. CABG (including the EXCEL) did no show differences in mortality at 5 years between the revascularization strategies.

Not even SYNTAX data at 10 years showed differences in mortality.

Unfortunately, the difference between all-cause and cardiovascular mortality was not mentioned in the BBC investigation. 

-The safety committee issued alerts that were not taken into account:

The independent safety monitoring committee often followed up on raw data and suggested staying on track as planned, with no amends. 

-The ESC/EAPCI/EACTS guidelines are not safe:

Guidelines are written based on a stack of evidence from multiple studies carried out by independent experts. The current guidelines (based partly on the EXCEL) suggest PCI can be considered a viable alternative for select patients with left main disease. 

2020-01-03-response-final

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...